This study evaluated the predictive value of @entity419 PET for distant @entity3 -free survival and peritoneal recurrence-free survival as well as recurrence-free survival and overall survival after curative surgical resection in @entity1 with advanced @entity356 (AGC). METHODS: Two hundred seventy-nine @entity1 with AGC who underwent preoperative @entity419 PET and subsequent curative surgical resection were included. The @entity5 -to-normal liver uptake ratio (TLR) of @entity5 was measured, and the prognostic significance of TLR and @entity5 factors for distant @entity3 -free survival, peritoneal recurrence-free survival, recurrence-free survival, and overall survival was assessed. RESULTS: The 5-y recurrence-free survival, peritoneal recurrence-free survival, distant @entity3 -free survival, and overall survival rates were 46.9%, 68.5%, 76.0%, and 58.1%, respectively. Depth of @entity5 invasion, lymph node @entity3 , lymphovascular invasion, and TLR were independent prognostic factors for both recurrence-free survival and overall survival (P<0.05). For distant @entity3 -free survival, lymphovascular invasion and TLR were independent risk factors (P<0.05). In @entity1 with a TLR of 2.0 or less, the 5-y distant @entity3 -free survival rate was 95.5%; in @entity1 with a TLR greater than 2.0, the 5-y distant @entity3 -free survival rate was 68.8%. For peritoneal recurrence-free survival, TLR showed no statistical significance (P=0.7) whereas pT stage, lymph node @entity3 , Lauren classification, and Bormann type were independent prognostic factors (P<0.05). CONCLUSION: @entity419 uptake of AGC is an independent prognostic factor for distant @entity3 -free survival, recurrence-free survival, and overall survival. The possibility of distant @entity3 during follow-up should be considered in @entity1 with high @entity419 uptake.

Relationship Between XXXX Uptake on PET and Recurrence Patterns After Curative Surgical Resection in @entity1 with Advanced @entity356 .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity419 :: ('MESH:D019788', 'Chemical') :: ['18F-FDG'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'cancer lesions'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis'] @entity356 :: ('MESH:D013274', 'Disease') :: ['gastric cancer']
@entity419 :: (MESH:D019788,Chemical) :: ['18F-FDG']
